Company intelligence / Profile preview
Eagle Pharmaceuticals
- Ownership
- Public · EGRX
- Employees
- ~125
- Development stage
- Other
Overview
Eagle Pharmaceuticals markets several FDA-approved products in oncology and critical care. Its commercial portfolio includes PEMFEXY® for lung cancer; RYANODEX® for malignant hyperthermia/exertional heatstroke; BENDEKA®/BELRAPZO® for CLL/NHL; TREAKISYM® in Japan via royalty agreement; BYFAVO® and BARHEMSYS®, both acquired with Acacia Pharma. Pipeline highlights include CAL02 in Phase II trials for severe pneumonia and EA‑114/fulvestrant targeting metastatic breast cancer. The company continues to generate revenue from marketed products while advancing new candidates through clinical development.
- Therapeutic areas
- OtherOncologyRare Diseases
- Modalities
- Small molecules (injectables and oral formulations)Reformulated drugs
- Industry
- Biotech
Drug pipeline
4 assets3 more assets in the full pipeline.
Partnerships
Financials
- Market cap
- $12.5M
- Total revenue
- $316.6M
- Enterprise value
- $69.6M
Beyond the preview
Go deeper on Eagle Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Eagle Pharmaceuticals.